Your World, Fully Explored.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Pope Francis
Mother's Day
Catholic Church
World War II
Artificial Intelligence
Vatican
Social Media
European Union
Parade
Drones
Military
Published • loading... • Updated

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Summary by Ground News
Humira has enjoyed high-priced U.S. exclusivity for 20 years. Its challengers could save the health care system $9 billion and herald savings from the whole class of drugs. The biosimilars work the same way as Humira, an injectable treatment for rheumatoid arthritis.

1 Articles

All
Left
Center
Right
1
Boston HeraldBoston Herald
Lean Right

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Humira has enjoyed high-priced U.S. exclusivity for 20 years. Its challengers could save the health care system $9 billion and herald savings from the whole class of drugs called biosimilars.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Boston Herald broke the news in Boston, United States on Friday, September 22, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Eureka, California

Eureka, California

News
For You
SearchBlindspotLocal